SEMA4

A story published by the CT Mirror on May 11 and republished by WSHU on May 12 about Sema4 and its COVID-19 testing contract with the state of Connecticut contained a number of errors.

When Alexion Pharmaceuticals announced last fall that it was moving its headquarters from New Haven to Boston, it was a blow to Connecticut’s bioscience…